Entrez Id: |
1589 |
Gene Symbol: |
CYP21A2 |
CYP21A2
|
cytochrome P450 family 21 subfamily A member 2
|
0.525 |
0.769 |
2.6E-04 |
Congenital adrenal hyperplasia due to 21 hydroxylase deficiency
|
disease |
0.800 |
None
|
0.976 |
208 |
55 |
1980 |
2020 |
Entrez Id: |
1589 |
Gene Symbol: |
CYP21A2 |
CYP21A2
|
cytochrome P450 family 21 subfamily A member 2
|
0.525 |
0.769 |
2.6E-04 |
Congenital adrenal hyperplasia
|
disease |
0.500 |
None
|
0.983 |
230 |
18 |
1983 |
2020 |
Entrez Id: |
1589 |
Gene Symbol: |
CYP21A2 |
CYP21A2
|
cytochrome P450 family 21 subfamily A member 2
|
0.525 |
0.769 |
2.6E-04 |
Late onset congenital adrenal hyperplasia
|
disease |
0.330 |
None
|
1.000 |
3 |
1 |
2008 |
2018 |
Entrez Id: |
1589 |
Gene Symbol: |
CYP21A2 |
CYP21A2
|
cytochrome P450 family 21 subfamily A member 2
|
0.525 |
0.769 |
2.6E-04 |
Hyperandrogenism, Nonclassic Type, due to 21-Hydroxylase Deficiency
|
disease |
0.300 |
strong
|
|
0 |
0 |
|
|
Entrez Id: |
1589 |
Gene Symbol: |
CYP21A2 |
CYP21A2
|
cytochrome P450 family 21 subfamily A member 2
|
0.525 |
0.769 |
2.6E-04 |
Adrenal hyperplasia
|
disease |
0.130 |
None
|
0.667 |
3 |
0 |
1990 |
2010 |
Entrez Id: |
1589 |
Gene Symbol: |
CYP21A2 |
CYP21A2
|
cytochrome P450 family 21 subfamily A member 2
|
0.525 |
0.769 |
2.6E-04 |
Lupus Erythematosus, Systemic
|
disease |
0.120 |
None
|
1.000 |
5 |
15 |
1990 |
2015 |
Entrez Id: |
1589 |
Gene Symbol: |
CYP21A2 |
CYP21A2
|
cytochrome P450 family 21 subfamily A member 2
|
0.525 |
0.769 |
2.6E-04 |
Adrenogenital Syndrome
|
disease |
0.110 |
None
|
1.000 |
1 |
0 |
2019 |
2019 |
Entrez Id: |
1589 |
Gene Symbol: |
CYP21A2 |
CYP21A2
|
cytochrome P450 family 21 subfamily A member 2
|
0.525 |
0.769 |
2.6E-04 |
Hypertensive disease
|
group |
0.110 |
None
|
< 0.001 |
1 |
1 |
2010 |
2010 |
Entrez Id: |
1589 |
Gene Symbol: |
CYP21A2 |
CYP21A2
|
cytochrome P450 family 21 subfamily A member 2
|
0.525 |
0.769 |
2.6E-04 |
Chronic active hepatitis
|
disease |
0.100 |
None
|
0.989 |
181 |
18 |
1986 |
2020 |
Entrez Id: |
1589 |
Gene Symbol: |
CYP21A2 |
CYP21A2
|
cytochrome P450 family 21 subfamily A member 2
|
0.525 |
0.769 |
2.6E-04 |
Deficiency of steroid 21-monooxygenase
|
disease |
0.100 |
None
|
0.970 |
165 |
17 |
1980 |
2020 |
Entrez Id: |
1589 |
Gene Symbol: |
CYP21A2 |
CYP21A2
|
cytochrome P450 family 21 subfamily A member 2
|
0.525 |
0.769 |
2.6E-04 |
21-hydroxylase deficiency
|
disease |
0.100 |
None
|
0.959 |
146 |
20 |
1980 |
2020 |
Entrez Id: |
1589 |
Gene Symbol: |
CYP21A2 |
CYP21A2
|
cytochrome P450 family 21 subfamily A member 2
|
0.525 |
0.769 |
2.6E-04 |
Age related macular degeneration
|
disease |
0.100 |
None
|
1.000 |
11 |
29 |
2010 |
2018 |
Entrez Id: |
1589 |
Gene Symbol: |
CYP21A2 |
CYP21A2
|
cytochrome P450 family 21 subfamily A member 2
|
0.525 |
0.769 |
2.6E-04 |
Hyperandrogenism
|
disease |
0.100 |
None
|
1.000 |
11 |
1 |
1997 |
2020 |
Entrez Id: |
1589 |
Gene Symbol: |
CYP21A2 |
CYP21A2
|
cytochrome P450 family 21 subfamily A member 2
|
0.525 |
0.769 |
2.6E-04 |
Multiple congenital anomalies
|
group |
0.100 |
None
|
1.000 |
9 |
1 |
1998 |
2015 |
Entrez Id: |
1589 |
Gene Symbol: |
CYP21A2 |
CYP21A2
|
cytochrome P450 family 21 subfamily A member 2
|
0.525 |
0.769 |
2.6E-04 |
Movement Disorders
|
group |
0.100 |
None
|
1.000 |
9 |
2 |
1998 |
2015 |
Entrez Id: |
1589 |
Gene Symbol: |
CYP21A2 |
CYP21A2
|
cytochrome P450 family 21 subfamily A member 2
|
0.525 |
0.769 |
2.6E-04 |
Triglycerides measurement
|
phenotype |
0.100 |
None
|
1.000 |
4 |
4 |
2012 |
2019 |
Entrez Id: |
1589 |
Gene Symbol: |
CYP21A2 |
CYP21A2
|
cytochrome P450 family 21 subfamily A member 2
|
0.525 |
0.769 |
2.6E-04 |
Schizophrenia
|
disease |
0.100 |
None
|
1.000 |
3 |
5 |
2017 |
2019 |
Entrez Id: |
1589 |
Gene Symbol: |
CYP21A2 |
CYP21A2
|
cytochrome P450 family 21 subfamily A member 2
|
0.525 |
0.769 |
2.6E-04 |
exudative macular degeneration
|
disease |
0.100 |
None
|
1.000 |
3 |
5 |
2012 |
2016 |
Entrez Id: |
1589 |
Gene Symbol: |
CYP21A2 |
CYP21A2
|
cytochrome P450 family 21 subfamily A member 2
|
0.525 |
0.769 |
2.6E-04 |
Type I Mucolipidosis
|
disease |
0.100 |
None
|
1.000 |
3 |
4 |
2000 |
2014 |
Entrez Id: |
1589 |
Gene Symbol: |
CYP21A2 |
CYP21A2
|
cytochrome P450 family 21 subfamily A member 2
|
0.525 |
0.769 |
2.6E-04 |
Exudative age-related macular degeneration
|
disease |
0.100 |
None
|
1.000 |
3 |
5 |
2012 |
2016 |
Entrez Id: |
1589 |
Gene Symbol: |
CYP21A2 |
CYP21A2
|
cytochrome P450 family 21 subfamily A member 2
|
0.525 |
0.769 |
2.6E-04 |
Rheumatoid Arthritis
|
disease |
0.100 |
None
|
1.000 |
3 |
46 |
2007 |
2011 |
Entrez Id: |
1589 |
Gene Symbol: |
CYP21A2 |
CYP21A2
|
cytochrome P450 family 21 subfamily A member 2
|
0.525 |
0.769 |
2.6E-04 |
Coronary Artery Disease
|
disease |
0.100 |
None
|
1.000 |
3 |
4 |
2017 |
2018 |
Entrez Id: |
1589 |
Gene Symbol: |
CYP21A2 |
CYP21A2
|
cytochrome P450 family 21 subfamily A member 2
|
0.525 |
0.769 |
2.6E-04 |
Drug-induced neutropenia
|
disease |
0.100 |
None
|
1.000 |
2 |
2 |
2016 |
2018 |
Entrez Id: |
1589 |
Gene Symbol: |
CYP21A2 |
CYP21A2
|
cytochrome P450 family 21 subfamily A member 2
|
0.525 |
0.769 |
2.6E-04 |
Multiple Sclerosis
|
disease |
0.100 |
None
|
1.000 |
2 |
12 |
2007 |
2010 |
Entrez Id: |
1589 |
Gene Symbol: |
CYP21A2 |
CYP21A2
|
cytochrome P450 family 21 subfamily A member 2
|
0.525 |
0.769 |
2.6E-04 |
Sarcoidosis
|
disease |
0.100 |
None
|
1.000 |
2 |
2 |
2012 |
2016 |